This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Medimmune Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jon Chesebrough: Innovator in Therapeutic Binding Molecules
Introduction
Jon Chesebrough, based in Gaithersburg, MD, is a prominent inventor recognized for his significant contributions to the field of cancer treatment. With a keen focus on therapeutic binding molecules, his innovations pave the way for advancements in medical science and patient care.
Latest Patents
Chesebrough holds one patent titled "Therapeutic Binding Molecules." This patent encompasses new binding molecules, such as antibodies, designed for the treatment of cancer. Additionally, it includes related antibody-drug conjugates that enhance therapeutic efficacy and specificity for cancer therapies.
Career Highlights
Jon Chesebrough works at Medimmune Limited, a leading biotechnology company dedicated to developing innovative medicines for patients with serious diseases. His role at Medimmune has allowed him to translate scientific discoveries into practical therapeutic solutions.
Collaborations
Throughout his career, Jon has collaborated with talented professionals, including Krista Lynne Kinneer and Gareth Charles Davies. These collaborations facilitate innovative approaches and enhance research and development efforts within the company.
Conclusion
Jon Chesebrough exemplifies the spirit of innovation in the field of healthcare. His work on therapeutic binding molecules highlights the importance of research and inventions in combating cancer. As he continues his journey at Medimmune Limited, the potential for future breakthroughs remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile